Loading...
ROCO
3105
Market cap1.26bUSD
May 14, Last price  
90.20TWD
1D
2.04%
1Q
-14.10%
Jan 2017
-0.77%
IPO
19.57%
Name

WIN Semiconductors Corp

Chart & Performance

D1W1MN
ROCO:3105 chart
P/E
49.78
P/S
2.19
EPS
1.81
Div Yield, %
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
-3.97%
Revenues
17.46b
+10.24%
4,790,143,0006,981,651,0008,901,273,00011,237,964,00010,481,303,0009,910,010,00012,015,747,00013,623,076,00017,086,355,00017,310,716,00021,377,724,00025,546,205,00026,182,376,00018,334,336,00015,836,498,00017,457,713,000
Net income
768m
P
559,444,0001,709,284,0001,278,610,0001,647,529,0001,811,510,0001,963,469,0002,671,627,0003,112,774,0003,764,200,0003,124,454,0004,474,399,0006,528,740,0005,454,962,0001,414,255,000-79,657,000768,133,000
CFO
4.90b
+14.77%
818,586,0002,607,889,0001,865,441,0002,890,306,0004,998,343,0003,829,874,0004,892,659,0003,786,500,0005,894,027,0005,479,518,0008,084,359,0008,755,021,0007,814,712,0005,968,368,0004,269,533,0004,900,014,000
Dividend
Jul 04, 20232.5 TWD/sh

Profile

WIN Semiconductors Corp. researches, develops, manufactures, markets, and sells gallium arsenide (GaAs) wafers in Taiwan, Asia, the Americas, and Europe. It offers GaAs monolithic microwave ICs (MMIC) and radio frequency ICs, as well as develops and trades in hog farming technology. The company also provides foundry services, testing services, and design support services, as well as high frequency packaging and final test services. In addition, it engages in investment, logistics management, and marketing activities; research, manufacture, and sale of high-density gene chips, biochip optical readers, and micro-electrophoresis analyzers; and farm feed development and trading activities. Further, the company develops and sells diagnostic tool for endometrial cancer; and offers information software services, biotechnology and pharmaceutical testing, and biotech research and development activities. WIN Semiconductors Corp. was incorporated in 1999 and is based in Taoyuan City, Taiwan.
IPO date
Oct 06, 2009
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
17,457,713
10.24%
15,836,498
-13.62%
18,334,336
-29.97%
Cost of revenue
16,695,592
15,961,533
16,850,461
Unusual Expense (Income)
NOPBT
762,121
(125,035)
1,483,875
NOPBT Margin
4.37%
8.09%
Operating Taxes
(7,017)
(121,054)
411,481
Tax Rate
27.73%
NOPAT
769,138
(3,981)
1,072,394
Net income
768,133
-1,064.30%
(79,657)
-105.63%
1,414,255
-74.07%
Dividends
(1,059,851)
(3,391,811)
Dividend yield
1.52%
5.84%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
3,834,781
7,864,796
1,834,717
Long-term debt
18,245,888
21,842,617
28,493,087
Deferred revenue
Other long-term liabilities
181,666
210,526
210,711
Net debt
(2,300,907)
3,177,224
5,571,643
Cash flow
Cash from operating activities
4,900,014
4,269,533
5,968,368
CAPEX
(1,221,551)
(3,208,720)
(7,191,351)
Cash from investing activities
(1,055,499)
(2,753,174)
(7,080,959)
Cash from financing activities
(8,938,763)
(1,676,146)
(5,023,285)
FCF
2,556,465
2,437,837
(1,477,178)
Balance
Cash
5,694,539
10,469,036
10,500,557
Long term investments
18,687,037
16,061,153
14,255,604
Excess cash
23,508,690
25,738,364
23,839,444
Stockholders' equity
23,256,843
25,382,143
29,760,972
Invested Capital
37,228,482
38,927,054
40,860,213
ROIC
2.02%
2.71%
ROCE
1.26%
2.29%
EV
Common stock shares outstanding
424,383
440,471
425,346
Price
112.00
-29.34%
158.50
16.12%
136.50
-63.55%
Market cap
47,530,882
-31.92%
69,814,654
20.25%
58,059,729
-65.78%
EV
46,249,922
74,386,012
65,492,380
EBITDA
5,461,683
4,614,348
5,787,190
EV/EBITDA
8.47
16.12
11.32
Interest
794,979
664,858
341,133
Interest/NOPBT
104.31%
22.99%